Nasdaq® NeuroInsights® Neurotech Index


The NASDAQ NeuroInsights Neurotech Index (NERV) is a pure play modified market-capitalization weighted index designed to track the performance of the leading neurotechnology companies which are listed and actively traded on one of the three major U.S. stock exchanges.

The Index includes companies researching, developing, manufacturing, and marketing pharmaceuticals, biologics, medical devices and diagnostics for the brain and nervous system.

Index companies are defined by NeuroInsights as significantly involved in neurotechnology and must meet rigorous market criteria including a $200 million market capitalization and a three-month average daily trading volume of 100,000 shares.
Index Components Performance

Index Historical Performance

Index Methodology and Inclusion Criteria

Licensing Information

Universe of Neurotech Stocks

About the Neurotechnology Industry
NERV is a price return index which is ordinarily calculated without regard to cash dividends on Index Securities. The Index commenced calculation with a value of 150.00 on September 25, 2007.